Post-UDS CIC: recommended for DLPP > 40, DSD, or Grade 5 VUR, start oxybutynin 0.2mg/kg TID
VUR: seen in 3-5% newborns, 30-40% by 5yo if untreated, treat with CIC + anticholinergics
Occult dysraphisms: if not diagnosed by age 3yo, 92% develop UMN or LMN lesion (tethered cord, lipoma compression)
Crede voiding: avoid, increases reflux and potential for upper tract damage
Cystatin C: serum levels provide more accurate estimate of GFR
Bowel function: managed with laxatives, enemas, frequent BMs, and manual stimulation
Antegrade continence enema (ACE): administered via appendicostomy or cecostomy, 1-2L fluid 4-7x weekly
Sexual function: 70-92% can obtain erection, 40-75% can ejaculate, 8-83% men and 23-69% women are sexually active, 70-80% able to achieve pregnancy
Management of Myelomeningocele Study (MOMS): prenatal surgery reduces fetal/neonatal death or CSF shunting (RR 0.7), but 40% still required shunting and pregnancy complications were higher and had higher risk for spinal cord tethering
Other neuromuscular disorders
Sacral agenesis: MRI confirms acute cutoff of conus at T12, obtain RUS/VCUG, manage based on UDS findings
Anorectal malformations: GU abnormalities more likely if supralevator (vs infralevator) fistula insertion, often have DO + DSD, obtain RUS, obtain UDS if bony abnormalities, spinal cord defect, or RUS/VCUG abnormalities
Post-pelvic surgery: due to splanchnic/hypogastric nerve damage, preop/postop UDS recommended if high risk for injury during surgery
Cerebral palsy: 16-94% have GU symptoms, mainly incontinence, upper tract injury is rare, manage based on individual picture
Spinal cord injury: acontractile bladder in acute setting, then may develop DO + DSD, minimal regain of function if cauda equina injured, protect upper tracts
Transverse myelitis: urinary retention common in acute setting, then develops into DO + DSD, 57-73% require CIC
Management Options
Goals (in order of priority): protect upper tracts, maintain continence, maintain independence, avoid reconstructive surgery
Most concerning finding is filling pressures > 40, increases risk for upper tract injury
Anticholinergics: improves capacity/compliance, decreases incontinence and catheterization episodes, side effects (dry mouth, constipation, blurred vision, dizziness, headaches) can lead to decreased compliance, no evidence cognitive impairment in children
Sympathomimetics: improve urethral resistance, but may cause dizziness, nausea, insomnia, headache, retention
Botox: 65-87% dryness after failing medical management + CIC, 360U max dose
Augmentation: for poorly compliant small capacity bladders, 0-29% require continued anticholinergics, 15% develop major complications (SBO, transfusions, perforation, UTI/pyelo), cystography diagnostic for augment perforation, 0.6% cancer risk
Vesicostomy: used for severe reflux despite CIC, CIC non-compliance, poor augment candidates, complications include prolapse, stenosis, bladder stones